Innoviva, Inc. (INVA) earnings
INVA earnings moved a median of -0.10% by the close. Quarterly and annual INVA reports and results, each read against the price at its own news timestamp. Back to the INVA overview →
25 measured INVA earnings events.
Where these INVA earnings landedvs 25 measured INVA earnings reactions
| Middle 50% of INVA earnings reactions | -2.36% to +0.88% |
|---|---|
| Median reaction (to close) | -0.10% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 INVA earnings events with a measured close landed between -2.36% and +0.88%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Innoviva, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.18% | -0.10% | |
| Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress | Press release | -1.18% | -0.10% | |
| Form 10-Q Innoviva, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.63% | -4.80% | |
| Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress | Press release | -1.63% | -4.80% | |
| Form 10-K/A Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.55% | +0.88% | |
| Form 10-K Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.97% | -5.84% | |
| Form 10-Q Innoviva, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.01% | +3.68% | |
| Innoviva Reports Third Quarter 2025 Financial Results; Highlights Recent Company Progress | Press release | -1.01% | +3.68% | |
| Form 10-Q Innoviva, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.08% | +1.09% | |
| Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress | Press release | +2.08% | +1.09% | |
| Form 10-Q Innoviva, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.80% | -0.96% | |
| Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress | Press release | -0.80% | -0.96% | |
| Form 10-K/A Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.06% | +0.52% | |
| Form 10-K Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.61% | -2.72% | |
| Form 10-Q Innoviva, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.26% | +0.55% | |
| Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress | Press release | +1.26% | +0.55% | |
| Form 10-Q Innoviva, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.75% | +7.11% | |
| Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress | Press release | +1.75% | +7.11% | |
| Form 10-Q Innoviva, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.09% | -2.36% | |
| Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress | Press release | -1.09% | -2.36% | |
| Form 10-K/A Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.33% | -0.26% | |
| Form 10-K/A Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.82% | -2.17% | |
| Form 10-K Innoviva, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.52% | -8.52% | |
| Form 10-Q Innoviva, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.21% | +0.30% | |
| Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress | Press release | -1.21% | +0.30% |
Keep exploring
More INVA: analyst actions → · SEC filings → · INVA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | 166 | -0.48% | 44% |
| CymaBay Therapeutics Inc. (CBAY) | 166 | +0.02% | 52% |
| MediWound Ltd. - Ordinary Shares (MDWD) | 166 | +0.11% | 53% |
| XBiotech Inc. (XBIT) | 165 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.